Does the amikacin effectiveness is reached in septic critically ill patient after the empirical daily dose against gram-negative mic 32mg/l strains? (2017)
- Authors:
- USP affiliated authors: SILVA JUNIOR, CARLINDO VIEIRA DA - FCF ; SANTOS, SILVIA REGINA CAVANI JORGE - FCF
- Unidade: FCF
- Subjects: BACTÉRIAS GRAM-NEGATIVAS; CHOQUE SÉPTICO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 53, suppl. 1, p. 56 res. FCF108, 2017
- Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo
-
ABNT
SOUZA, Vanessa Kasubeck de et al. Does the amikacin effectiveness is reached in septic critically ill patient after the empirical daily dose against gram-negative mic 32mg/l strains?. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 16 abr. 2024. , 2017 -
APA
Souza, V. K. de, Silva Júnior, J. M. da, Campos, E. V., Oliveira, A. M. R. R. de, Gomez, D. de S., Silva Junior, C. V. da, & Santos, S. R. C. J. (2017). Does the amikacin effectiveness is reached in septic critically ill patient after the empirical daily dose against gram-negative mic 32mg/l strains? Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Souza VK de, Silva Júnior JM da, Campos EV, Oliveira AMRR de, Gomez D de S, Silva Junior CV da, Santos SRCJ. Does the amikacin effectiveness is reached in septic critically ill patient after the empirical daily dose against gram-negative mic 32mg/l strains? Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 56 res. FCF108.[citado 2024 abr. 16 ] -
Vancouver
Souza VK de, Silva Júnior JM da, Campos EV, Oliveira AMRR de, Gomez D de S, Silva Junior CV da, Santos SRCJ. Does the amikacin effectiveness is reached in septic critically ill patient after the empirical daily dose against gram-negative mic 32mg/l strains? Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 56 res. FCF108.[citado 2024 abr. 16 ] - PK/PD correlation of vancomycin for dose adjustment for the control of infections in pediatric critical burn patients
- Correlação PK/PD de carbapenêmicos em pacientes críticos pediátricos grandes queimados para o controle da sepse
- Vancomycin daily dose recommended to pediatric septic burn patients against staphylococcus spp. and effectiveness based on ratio area under the curve and mic
- A new carbapenem agent for the control of severe infection caused by the most agressive nosocomial strains in critically ill patients
- Triazoles or echinocandins antifungal therapy against candida glabrata in sepsis?
- PK modeling of vancomycin-piperacillin for the control of severe infections in critical burn patients for dose adjustment purpose
- Is vancomycin therapeutic target against Staphylococcus SPP MIC1mg/L achieved after the empirical dose regimen recommended to critically septic pediatrics?
- Vancomycin pk/pd correlation for the control of infection in critical burn patients with sepsis
- Vancomycin effectiveness by PK/PD correlation in burn patients
- PK/PD correlation for imipenem effectiveness in burn patients
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
